{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:27Z","timestamp":1761101007301},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/cji.0b013e3181635e7f","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:44:56Z","timestamp":1236192296000},"page":"334-344","source":"Crossref","is-referenced-by-count":8,"title":["Migration Patterns of Nonspecifically Activated Versus Nonactivated Nonhuman Primate T Lymphocytes: Preferential Homing of Activated Autologous CD8+ T Cells in the Rectal Mucosa"],"prefix":"10.1097","volume":"31","author":[{"given":"Kristina","family":"Allers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9e","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Moos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Eisenbl\u00e4tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Stahl-Hennig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz-Josef","family":"Kaup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ignatius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210219","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"R2-2-20210219","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/oxfordjournals.jncimonographs.a024180","article-title":"Immunotherapy for Epstein-Barr virus-associated cancers","volume":"23","author":"Rooney","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R3-2-20210219","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jcp.39.6.585","article-title":"Lymphocytic infiltration and survival in rectal cancer","volume":"39","author":"Jass","year":"1986","journal-title":"J Clin Pathol"},{"key":"R4-2-20210219","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6","article-title":"Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer","volume":"182","author":"Ropponen","year":"1997","journal-title":"J Pathol"},{"key":"R5-2-20210219","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"R6-2-20210219","first-page":"3491","article-title":"CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res"},{"key":"R7-2-20210219","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9440(10)61695-1","article-title":"Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis","volume":"159","author":"Guidoboni","year":"2001","journal-title":"Am J Pathol"},{"key":"R8-2-20210219","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-2-20210219","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-06-4806","article-title":"The adaptive immunologic microenvironment in colorectal cancer: a novel perspective","volume":"67","author":"Galon","year":"2007","journal-title":"Cancer Res"},{"key":"R10-2-20210219","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.4049\/jimmunol.163.11.6292","article-title":"Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression","volume":"163","author":"Lee","year":"1999","journal-title":"J Immunol"},{"key":"R11-2-20210219","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/10430340050015635","article-title":"Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line","volume":"11","author":"Osanto","year":"2000","journal-title":"Hum Gene Ther"},{"key":"R12-2-20210219","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.gt.3300874","article-title":"Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine","volume":"6","author":"Rodolfo","year":"1999","journal-title":"Gene Ther"},{"key":"R13-2-20210219","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.4049\/jimmunol.173.12.7125","article-title":"Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy","volume":"173","author":"Robbins","year":"2004","journal-title":"J Immunol"},{"key":"R14-2-20210219","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.4049\/jimmunol.173.12.7622","article-title":"Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma","volume":"173","author":"Zhou","year":"2004","journal-title":"J Immunol"},{"key":"R15-2-20210219","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002371-200501000-00007","article-title":"Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy","volume":"28","author":"Zhou","year":"2005","journal-title":"J Immunother (1997)"},{"key":"R16-2-20210219","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.jid.5700580","article-title":"Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors","volume":"127","author":"Le Gal","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R17-2-20210219","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1054-3589(00)49034-4","article-title":"Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention","volume":"49","author":"Hirsch","year":"2000","journal-title":"Adv Pharmacol"},{"key":"R18-2-20210219","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1472-9792(02)00059-8","article-title":"Non-human primates: a model for tuberculosis research","volume":"83","author":"Flynn","year":"2003","journal-title":"Tuberculosis (Edinb)"},{"key":"R19-2-20210219","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1099-1654(199901\/03)9:1<57::AID-RMV237>3.0.CO;2-1","article-title":"Simian immunodeficiency virus as a model of human HIV disease","volume":"9","author":"Geretti","year":"1999","journal-title":"Rev Med Virol"},{"key":"R20-2-20210219","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1128\/JVI.73.11.9576-9583.1999","article-title":"Pathogenesis of experimental rhesus cytomegalovirus infection","volume":"73","author":"Lockridge","year":"1999","journal-title":"J Virol"},{"key":"R21-2-20210219","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1128\/IAI.64.8.2885-2891.1996","article-title":"Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease","volume":"64","author":"Dubois","year":"1996","journal-title":"Infect Immun"},{"key":"R22-2-20210219","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jim.2004.06.019","article-title":"Chemokine networks and in vivo T-lymphocyte trafficking in nonhuman primates","volume":"293","author":"Clay","year":"2004","journal-title":"J Immunol Methods"},{"key":"R23-2-20210219","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1128\/JVI.79.21.13759-13768.2005","article-title":"Distinct chemokine triggers and in vivo migratory paths of fluorescein dye-labeled T Lymphocytes in acutely simian immunodeficiency virus SIVmac251-infected and uninfected macaques","volume":"79","author":"Clay","year":"2005","journal-title":"J Virol"},{"key":"R24-2-20210219","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L","article-title":"Activation induces rapid and profound alterations in the trafficking of T cells","volume":"30","author":"Hamann","year":"2000","journal-title":"Eur J Immunol"},{"key":"R25-2-20210219","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000074896","article-title":"Visualizing T cell migration in vivo","volume":"132","author":"Iparraguirre","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"R26-2-20210219","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.LAB.0000062852.80567.90","article-title":"Analyzing the migration of labeled T cells in vivo: an essential approach with challenging features","volume":"83","author":"Westermann","year":"2003","journal-title":"Lab Invest"},{"key":"R27-2-20210219","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0022-1759(90)90322-M","article-title":"New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy","volume":"133","author":"Weston","year":"1990","journal-title":"J Immunol Methods"},{"key":"R28-2-20210219","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0091-679X(08)60547-6","article-title":"Fluorescent cell labeling for in vivo and in vitro cell tracking","volume":"33","author":"Horan","year":"1990","journal-title":"Methods Cell Biol"},{"key":"R29-2-20210219","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-1759(94)90236-4","article-title":"Determination of lymphocyte division by flow cytometry","volume":"171","author":"Lyons","year":"1994","journal-title":"J Immunol Methods"},{"key":"R30-2-20210219","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1440-1711.1999.00871.x","article-title":"Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven","volume":"77","author":"Fazekas de St Groth","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"R31-2-20210219","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1440-1711.1999.00868.x","article-title":"The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo","volume":"77","author":"Mintern","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"R32-2-20210219","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2249.1994.tb07014.x","article-title":"Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea\/Wasting Syndrome Study Group","volume":"95","author":"Schneider","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"R33-2-20210219","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.4049\/jimmunol.165.11.6047","article-title":"Tumor-specific CD4+T cells have a major \u201cpost-licensing\u201d role in CTL mediated anti-tumor immunity","volume":"165","author":"Marzo","year":"2000","journal-title":"J Immunol"},{"key":"R34-2-20210219","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help","volume":"300","author":"Sun","year":"2003","journal-title":"Science"},{"key":"R35-2-20210219","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4049\/jimmunol.164.2.562","article-title":"Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen","volume":"164","author":"Surman","year":"2000","journal-title":"J Immunol"},{"key":"R36-2-20210219","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: induction of \u201cself\u201d-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J Exp Med"},{"key":"R37-2-20210219","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.1995.13.8.1939","article-title":"Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study","volume":"13","author":"Goedegebuure","year":"1995","journal-title":"J Clin Oncol"},{"key":"R38-2-20210219","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1200\/JCO.1998.16.8.2752","article-title":"Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer","volume":"16","author":"Curti","year":"1998","journal-title":"J Clin Oncol"},{"key":"R39-2-20210219","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients","volume":"26","author":"Dudley","year":"2003","journal-title":"J Immunother (1997)"},{"key":"R40-2-20210219","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-1759(87)80018-2","article-title":"Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials","volume":"102","author":"Topalian","year":"1987","journal-title":"J Immunol Methods"},{"key":"R41-2-20210219","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat Biotechnol"},{"key":"R42-2-20210219","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm869","article-title":"Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells","volume":"9","author":"Oelke","year":"2003","journal-title":"Nat Med"},{"key":"R43-2-20210219","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.157.9.4079","article-title":"Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus","volume":"157","author":"Yee","year":"1996","journal-title":"J Immunol"},{"key":"R45-2-20210219","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00002371-200109000-00003","article-title":"Immune Modulation in cancer patients after adoptive transfer of Anti-CD3\/Anti-CD28-costimulated T cells-phase i clinical trial","volume":"24","author":"Lum","year":"2001","journal-title":"J Immunother"},{"key":"R46-2-20210219","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.4049\/jimmunol.142.6.1854","article-title":"Leu 23 induction as an early marker of functional CD3\/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C","volume":"142","author":"Testi","year":"1989","journal-title":"J Immunol"},{"key":"R47-2-20210219","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2004.02.005","article-title":"Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases","volume":"93","author":"Tlaskalova-Hogenova","year":"2004","journal-title":"Immunol Lett"},{"key":"R48-2-20210219","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/JVI.68.12.8056-8063.1994","article-title":"CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection","volume":"68","author":"Matloubian","year":"1994","journal-title":"J Virol"},{"key":"R49-2-20210219","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.vaccine.2006.07.055","article-title":"Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine","volume":"25","author":"Cui","year":"2007","journal-title":"Vaccine"},{"key":"R50-2-20210219","first-page":"63","article-title":"Biodegradable polymer microspheres as vaccine adjuvants and delivery systems","volume":"92","author":"Gupta","year":"1998","journal-title":"Dev Biol Stand"},{"key":"R51-2-20210219","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(01)00477-X","article-title":"Generation of high quantities of viral and tumor-specific human CD4+ and CD8+T-cell clones using peptide pulsed mature dendritic cells","volume":"258","author":"Fonteneau","year":"2001","journal-title":"J Immunol Methods"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CJI.0b013e3181635e7f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T07:16:42Z","timestamp":1684912602000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002371-200805000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181635e7f","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}